About
Cannabis-derived drugs, psychedelics
Areas of Focus
Categories
Cannabis & MarijuanaPsychedelic
Team (26)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
121
By Phase
NA: 1PHASE1: 1PHASE2: 2
By Status
COMPLETED: 2TERMINATED: 2
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06505239Lead Sponsor
Assessing the Safety and Efficacy of FSD-F2R6-A-CP in Volunteers in an Induced State of Alcohol Intoxication
NACompleted
26 participants
Started: Jul 12, 2024 · Completed: Nov 7, 2024
NCT05821387Lead Sponsor
Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Food of Lucid-21-302 in Healthy Volunteers
PHASE1Completed
40 participants
Started: Mar 22, 2023 · Completed: Jul 29, 2023
NCT05652907Lead Sponsor
Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD)
PHASE2Terminated
2 participants
Started: Jan 19, 2023 · Completed: May 24, 2023
NCT04619706Lead Sponsor
Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19
PHASE2Terminated
53 participants
Started: Dec 14, 2020 · Completed: Aug 24, 2021
Locations (1)
Headquarters
Toronto, ON, Canada
Map
Loading map...